Kurv South Bay V & VI_Property for Sale
Kurv South Bay V & VI_Property for Sale

Kurv South Bay V & VI

159 E Rosecrans Ave, Los Angeles, CA, 90061, US

Description

JLL Industrial Capital Markets, serving as the exclusive advisor, is pleased to present the opportunity to acquire the fee-simple interest in Kurv South Bay V & VI (the “Properties” or “Project”) — two Class A, industrial facilities located in the South Bay submarket of Los Angeles, totaling ±208,261 SF on ±9.16 acres. The Project is fully leased to California Compounding, a pharmaceutical company specializing in the manufacturing of peptides, with 4.8 years of term remaining, in a location that is mission-critical to the tenant’s manufacturing operations within one of the most supply-constrained industrial markets in the United States. The South Bay has emerged as one of Los Angeles’ most sought-after submarkets for advanced manufacturing, aerospace and defense, and ancillary industrial uses, a wave of demand that is driving rents higher and tightening availability across the submarket.


Constructed in 2022, the Properties offer institutional-quality specifications including 32’ clear heights, ESFR sprinklers, 2,000 amps of power, and 265 auto parking stalls across both buildings. Located at the intersection of Rosecrans Avenue and Main Street in Gardena/Los Angeles, the Project benefits from an infill location within minutes of the Twin Ports of Los Angeles and Long Beach, LAX, and a dense aerospace and defense manufacturing ecosystem that has driven sustained industrial demand throughout the South Bay. This ecosystem — anchored by major programs from Anduril, SpaceX, Northrop Grumman, Raytheon, L3Harris, and Boeing — has enabled aerospace and defense tenants to sign leases at $2.25 - $3.00 PSF/mo NNN, a meaningful increase in rates YoY, underscoring the insatiable demand the market has seen. This demand is reflected in the submarket’s broader fundamentals: South Bay net absorption swung from -992,093 SF in Q1 2025 to a positive 517,030 SF in Q1 2026, and Class A vacancy tightened 200 basis points quarter-over-quarter in Q1 2026 outperforming the broader Los Angeles market. The Project has a new CUP, which allows for manufacturing and warehouse usage for the next 20 years. Kurv South Bay V & VI presents investors with an irreplaceable infill location that is mission-critical to the tenant’s manufacturing operations, at a basis that is significantly below today’s replacement cost — a combination that is functionally impossible to recreate in the current regulatory and land constrained environment of the Los Angeles South Bay.

...

Attributes

Building area gross
107,733 sf
Land area gross
5.08 acres

Media

Investment highlights

  1. 100% leased to a pharmaceutical company specializing in peptide manufacturing—a rapidly expanding segment of the bio-pharmaceutical industry driven by surging demand for GLP-1 therapies, oncology treatments, and next-generation drug delivery platforms.
  2. The lease is guaranteed by Thaeta Scientific, which operates an affiliated Burbank manufacturing facility generating approximately $2M per month in revenue — providing Landlord with recourse to an operating platform with a demonstrated revenue base.
  3. Pharmaceutical tenants represent one of the most credit resilient categories in industrial real estate, characterized by long operating commitments and mission-critical space requirements.
  4. California’s licensing rules block out-of-state 503A/503B facilities from shipping into the state, positioning California Compounding as a dominant in-state supplier.
  5. Limited suitable alternatives exist for qualified pharmaceutical manufacturing space within infill Southern California, reinforcing tenant retention and releasing defensibility.
Kurv South Bay V & VI 4_Property for Sale
Kurv South Bay V & VI 4_Property for Sale

Contact brokers

Kurv South Bay V & VI (0 Properties)

Similar properties

View moreChevron Right
Do you have any questions? Visit our FAQ page
View FAQ PageArrow Right

JLL Financing

We partner with investors to structure smarter financing and optimise portfolio performance. Contact us to see a brighter way with our team.
Last updated Aug 13, 2026